Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brus

Showing results (641-650 of 670) with videos related to

Pageof 67
Sort By:
ACS Applied Materials & Interfaces|August 28, 2025
Unveiling Spin Selective Mechanism toward Very Large Spin Signals in Black Phosphorus 2D Semiconductor Spintronics DevicesMarta Galbiati, Simon M-M Dubois, Hao Wei, et al.
ACS Nano|November 28, 2019
Band-Structure Spin-Filtering in Vertical Spin Valves Based on Chemical Vapor Deposited WS<sub>2</sub>Victor Zatko, Marta Galbiati, Simon Mutien-Marie Dubois, et al.
Nature Communications|February 16, 2020
Perovskite-molecule composite thin films for efficient and stable light-emitting diodesHeyong Wang, Felix Utama Kosasih, Hongling Yu, et al.
PLOS Global Public Health|September 11, 2023
Assessing independence in mobility activities in trauma care: Validity and reliability of the Activity Independence Measure-Trauma (AIM-T) in humanitarian settingsBérangère Gohy, Christina H Opava, Johan von Schreeb, et al.
PLOS Global Public Health|February 28, 2024
Correction: Assessing independence in mobility activities in trauma care: Validity and reliability of the Activity Independence Measure-Trauma (AIM-T) in humanitarian settingsBérangère Gohy, Christina H Opava, Johan von Schreeb, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategiesW Kievit, J Fransen, E M Adang, et al.
The Journal of Rheumatology|September 3, 2011
Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritisMarlies Blom, Wietske Kievit, A Rogier T Donders, et al.
Pediatric Hematology and Oncology|October 7, 2020
Serum hepcidin concentrations in relation to iron status in children with type 1 diabetesMirjam Vreugdenhil, Marjolijn D Akkermans, Rachel P L van Swelm, et al.
Annals of the Rheumatic Diseases|January 5, 2008
The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice dataW Kievit, E M Adang, J Fransen, et al.
ACS Omega|January 2, 2023
Effect of Electron and Proton Irradiation on Structural and Electronic Properties of Carbon NanowallsYerassyl Yerlanuly, Rakhymzhan Ye Zhumadilov, Igor V Danko, et al.
Pageof 67

Showing results (641-650 of 670) with videos related to

Sort By:
Pageof 67
ACS Applied Materials & Interfaces|August 28, 2025
Unveiling Spin Selective Mechanism toward Very Large Spin Signals in Black Phosphorus 2D Semiconductor Spintronics DevicesMarta Galbiati, Simon M-M Dubois, Hao Wei, et al.
ACS Nano|November 28, 2019
Band-Structure Spin-Filtering in Vertical Spin Valves Based on Chemical Vapor Deposited WS<sub>2</sub>Victor Zatko, Marta Galbiati, Simon Mutien-Marie Dubois, et al.
Nature Communications|February 16, 2020
Perovskite-molecule composite thin films for efficient and stable light-emitting diodesHeyong Wang, Felix Utama Kosasih, Hongling Yu, et al.
PLOS Global Public Health|September 11, 2023
Assessing independence in mobility activities in trauma care: Validity and reliability of the Activity Independence Measure-Trauma (AIM-T) in humanitarian settingsBérangère Gohy, Christina H Opava, Johan von Schreeb, et al.
PLOS Global Public Health|February 28, 2024
Correction: Assessing independence in mobility activities in trauma care: Validity and reliability of the Activity Independence Measure-Trauma (AIM-T) in humanitarian settingsBérangère Gohy, Christina H Opava, Johan von Schreeb, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategiesW Kievit, J Fransen, E M Adang, et al.
The Journal of Rheumatology|September 3, 2011
Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritisMarlies Blom, Wietske Kievit, A Rogier T Donders, et al.
Pediatric Hematology and Oncology|October 7, 2020
Serum hepcidin concentrations in relation to iron status in children with type 1 diabetesMirjam Vreugdenhil, Marjolijn D Akkermans, Rachel P L van Swelm, et al.
Annals of the Rheumatic Diseases|January 5, 2008
The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice dataW Kievit, E M Adang, J Fransen, et al.
ACS Omega|January 2, 2023
Effect of Electron and Proton Irradiation on Structural and Electronic Properties of Carbon NanowallsYerassyl Yerlanuly, Rakhymzhan Ye Zhumadilov, Igor V Danko, et al.
Pageof 67